SCHEMBL3405698

SCHEMBL3405698

Nc1c(=O)[nH]n2c(=O)c3ccccc3[nH]c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
ADORA3 P0DMS8 1/20 0.44
ADORA2A P29274 1/20 0.44
ADORA2B P29275 1/20 0.44
ADORA1 P30542 1/20 0.44
RNASEH1 O60930 1/20 0.44
ERCC1 P07992 1/20 0.44
ERCC5 P28715 1/20 0.44
FEN1 P39748 1/20 0.44
ERCC4 Q92889 1/20 0.44
KDM4E B2RXH2 7/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
HPGD P15428 2/20 0.43
NTRK1 P04629 1/20 0.42
MAPK8 P45983 1/20 0.42
MAPK9 P45984 1/20 0.42
MAPK10 P53779 1/20 0.42
NTRK3 Q16288 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3408234 0.77 KDM4E (0.54) ALDH1A1CA12CA9ADORA3ADORA2A
SCHEMBL3407406 0.71 BRD4 (0.46) ALDH1A1CA12CA9ADORA3ADORA2A
SCHEMBL3411281 0.71 EGFR (0.52) ALDH1A1ADORA3MAPK10MEN1KMT2A
SCHEMBL3411555 0.71 ALDH1A1 (0.46) ALDH1A1ADORA3KDM4EHPGDALOX5
SCHEMBL3407318 0.70 ALDH1A1 (0.53) ALDH1A1ADORA3KDM4ESMN1; SMN2HPGD
SCHEMBL6343134 0.67 KDM4E (0.62) ALDH1A1CA12CA9KDM4ESMN1; SMN2
SCHEMBL3411799 0.67 ALDH1A1 (0.46) ALDH1A1CA12CA9ADORA3ADORA2A
SCHEMBL3754362 0.65 ALDH1A1 (1.00) ALDH1A1CA12CA9ADORA3ADORA2A
SCHEMBL16474145 0.64 ALOX5 (0.59) ALDH1A1CA12CA9ADORA3ADORA2A
SCHEMBL30623756 0.63 KDM4E (0.69) ALDH1A1KDM4ESMN1; SMN2HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2264035-A1 Glycine B antagonists Merz Pharma GmbH & Co. KGaA (DE) 2010-12-22 EP disclosed